IRF2BPL transcriptionally regulates IGFBP2 to promote tumor progression and suppresses immune cell infiltration in esophageal squamous cell carcinoma

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.

PubMed  Google Scholar 

Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4:47–53.

PubMed  PubMed Central  Google Scholar 

Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, et al. The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology. 2022;163:649–58.e642.

Article  PubMed  Google Scholar 

Deboever N, Jones CM, Yamashita K, Ajani JA, Hofstetter WL. Advances in diagnosis and management of cancer of the esophagus. BMJ. 2024;385:e074962.

Article  CAS  PubMed  Google Scholar 

Ajani JA, D’Amico TA, Bentrem DJ, Chao J, Corvera C, Das P, et al. Esophageal and Esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17:855–83.

Article  CAS  PubMed  Google Scholar 

Huang J, Xu J, Chen Y, Zhuang W, Zhang Y, Chen Z, et al. Camrelizumab versus investigator’s choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study. Lancet Oncol. 2020;21:832–42.

Article  CAS  PubMed  Google Scholar 

Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem. 1998;67:425–79.

Article  CAS  PubMed  Google Scholar 

Komander D, Clague MJ, Urbé S. Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol. 2009;10:550–63.

Article  CAS  PubMed  Google Scholar 

Martínez-Jiménez F, Muiños F, López-Arribillaga E, Lopez-Bigas N, Gonzalez-Perez A. Systematic analysis of alterations in the ubiquitin proteolysis system reveals its contribution to driver mutations in cancer. Nat Cancer. 2020;1:122–35.

Tokheim C, Wang X, Timms RT, Zhang B, Mena EL, Wang B, et al. Systematic characterization of mutations altering protein degradation in human cancers. Mol Cell. 2021;81:1292–308.e1211.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoeller D, Hecker CM, Dikic I. Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat Rev Cancer. 2006;6:776–88.

Article  CAS  PubMed  Google Scholar 

Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y, et al. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol Cancer. 2024;23:148.

Article  PubMed  PubMed Central  Google Scholar 

Li L, Zhu R, Zhou H, Cui CP, Yu X, Liu Y, et al. All-Trans retinoic acid promotes a tumor suppressive OTUD6B-β-TrCP-SNAIL Axis in esophageal squamous cell carcinoma and enhances immunotherapy. Adv Sci. 2023;10:e2207458.

Article  Google Scholar 

Zhang H, Han Y, Xiao W, Gao Y, Sui Z, Ren P, et al. USP4 promotes the proliferation, migration, and invasion of esophageal squamous cell carcinoma by targeting TAK1. Cell Death Dis. 2023;14:730.

Article  PubMed  PubMed Central  Google Scholar 

Zhao X, Ma Y, Li J, Sun X, Sun Y, Qu F, et al. The AEG-1-USP10-PARP1 axis confers radioresistance in esophageal squamous cell carcinoma via facilitating homologous recombination-dependent DNA damage repair. Cancer Lett. 2023;577:216440.

Article  CAS  PubMed  Google Scholar 

Wang Q, Wu L, Cao R, Gao J, Chai D, Qin Y, et al. Fbxo45 promotes the malignant development of esophageal squamous cell carcinoma by targeting GGNBP2 for ubiquitination and degradation. Oncogene. 2022;41:4795–807.

Article  CAS  PubMed  Google Scholar 

Wang L, Liu C, Li L, Wei H, Wei W, Zhou Q, et al. RNF20 regulates oocyte meiotic spindle assembly by recruiting TPM3 to centromeres and spindle poles. Adv Sci. 2024;11:e2306986.

Article  Google Scholar 

Wang Z, Yan M, Ye L, Zhou Q, Duan Y, Jiang H, et al. VHL suppresses autophagy and tumor growth through PHD1-dependent Beclin1 hydroxylation. EMBO J. 2024;43:931–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu R, Han H, Chu S, Qin L, Du M, Ma Y, et al. Cullin 4B-RING E3 ligase negatively regulates the immunosuppressive capacity of mesenchymal stem cells by suppressing iNOS. Cell Death Differ. 2024;32:149–61.

Zhao D, Qiang L, Lei Z, Ge P, Lu Z, Wang Y, et al. TRIM27 elicits protective immunity against tuberculosis by activating TFEB-mediated autophagy flux. Autophagy. 2024;20:1483–504.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rampazzo A, Pivotto F, Occhi G, Tiso N, Bortoluzzi S, Rowen L, et al. Characterization of C14orf4, a novel intronless human gene containing a polyglutamine repeat, mapped to the ARVD1 critical region. Biochem Biophys Res Commun. 2000;278:766–74.

Article  CAS  PubMed  Google Scholar 

Heger S, Mastronardi C, Dissen GA, Lomniczi A, Cabrera R, Roth CL, et al. Enhanced at puberty 1 (EAP1) is a new transcriptional regulator of the female neuroendocrine reproductive axis. J Clin Invest. 2007;117:2145–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bauersachs D, Bomholtz L, del Rey Mateos S, Kühn R, Lisowski P. Novel human neurodevelopmental and neurodegenerative disease associated with IRF2BPL gene variants—mechanisms and therapeutic avenues. Front Neurosci. 2024;18:1426177.

Sinha Ray S, Dutta D, Dennys C, Powers S, Roussel F, Lisowski P, et al. Mechanisms of IRF2BPL-related disorders and identification of a potential therapeutic strategy. Cell Rep. 2022;41:111751.

Article  CAS  PubMed  Google Scholar 

Marcogliese PC, Dutta D, Ray SS, Dang NDP, Zuo Z, Wang Y, et al. Loss of IRF2BPL impairs neuronal maintenance through excess Wnt signaling. Sci Adv. 2022;8:eabl5613.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Higashimori A, Dong Y, Zhang Y, Kang W, Nakatsu G, Ng SSM, et al. Forkhead Box F2 suppresses gastric cancer through a novel FOXF2–IRF2BPL–β-catenin signaling axis. Cancer Res. 2018;78:1643–56.

Article  CAS  PubMed  Google Scholar 

Yokoyama A, Kouketsu T, Otsubo Y, Noro E, Sawatsubashi S, Shima H, et al. Identification and functional characterization of a novel androgen receptor coregulator, EAP1. J Endocr Soc. 2021;5:bvab150.

Article  PubMed  PubMed Central  Google Scholar 

Wang J, Yu X, Gong W, Liu X, Park KS, Ma A, et al. EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis. Nat Cell Biol. 2022;24:384–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yeung KT, Das S, Zhang J, Lomniczi A, Ojeda SR, Xu CF, et al. A novel transcription complex that selectively modulates apoptosis of breast cancer cells through regulation of FASTKD2. Mol Cell Biol. 2011;31:2287–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Y, Zhang Y, Wang D, Zhang Y, Zhang J, Zhang Y, et al. USP29 enhances chemotherapy-induced stemness in non-small cell lung cancer via stabilizing Snail1 in response to oxidative stress. Cell Death Dis. 2020;11:796.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinforma. 2013;14:7.

Article  Google Scholar 

Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243–59.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yan Q, Chen BJ, Hu S, Qi SL, Li LY, Yang JF, et al. Emerging role of RNF2 in cancer: from bench to bedside. J Cell Physiol. 2021;236:5453–65.

Article  CAS  PubMed 

Comments (0)

No login
gif